April 19, 2017 — Siemens Healthineers plans to expand itsPopulation Health Management (PHM)portfolio with the acquisition of Medicalis Corp. based in San Francisco and Kitchener, Ontario. Medicalis is a leading provider of clinical decision support (CDS) solutions at the point of order entry, imaging workflow (IW) management and referral management (RM).
By incorporating these offerings into its PHM portfolio, Siemens Healthineers will enable healthcare providers to effectively bridge between PHM at the health system level and at the departmental level.
The newly-acquired Population Health Management portfolio will extend the Siemens Healthineers strategy for Value-Based Healthcare across the health system enterprise and hospital departmental levels:
- Clinical decision support (CDS)根据2014年医疗保险保护法(PAMA)的定义,提供了一种机制,以检查成像指令的适当性,并使医疗保健提供者根据他们的适当使用标准(AUC),基于证据和最佳实践来定义和发展他们的护理标准。Today, 20–30 percent of high-tech imaging procedures fail to provide information that improves patient welfare and, therefore, may represent, at least in part, unnecessary imaging services;
- Imaging workfloworchestrates the interpreting physician desktop, streamlining workflow, and standardization of diagnostic pathways for high-impact disease states. It ensures the right specialist, the right tools, a timely read and prevention of care gaps; and
- Referral management helps to avoid breaks in care by providing simple appointment scheduling tools, which help a patient schedule examinations in their network. This avoids leakage of patient information to another health system, which breaks communication and causes lost revenue.
在短期内,Medicalis开发的解决方案有望解决整合提供商的迫切需求,以协调和标准化其成像工作流程,并实现PAMA的遵守,PAMA预计将于2018年1月1日生效,要求在某些高级成像测试点进行适当CDS咨询。西门子健康工程师相信,这些解决方案将使供应商在保持对内容控制的同时实现PAMA合规,允许他们超越简单的合规,真正建立基于证据和直接卫生系统经验的不断发展的护理标准。
The solutions developed by Medicalis allow networks of hospitals (health systems/integrated delivery networks) to improve physician productivity, manage patient referrals, and scheduling to enhance the relationship with the patient and ensure clinically appropriate imaging and tests to reduce inappropriate utilization.
The acquisition agreement was signed in April 2017. Terms of the transaction are not disclosed. The closing of the acquisition is subject to customary closing conditions.
For more information:www.usa.healthcare.siemens.com